Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors

Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors

US Patent 11202779 · Granted Dec 21, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of cannabinoids in treating anti-depressant-induced female sexual dysfunctio2023
Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases2020
Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases2020
Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases2020
Combinations for the treatment of neoplasms using quiescent cell targeting with 2019
Combinations for the treatment of neoplasms using quiescent cell targeting with 2019
Combinations for the treatment of neoplasms using quiescent cell targeting with 2019
Combinations for the treatment of neoplasms using quiescent cell targeting with 2019
Combinations for the treatment of neoplasms using quiescent cell targeting with 2019
Combinations for the treatment of neoplasms using quiescent cell targeting and i2019
Combinations for the treatment of neoplasms using quiescent cell targeting and i2019
Combinations for the treatment of neoplasms using quiescent cell targeting and i2019